| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 12.60% | — | — | 1.24% | 25.43% | 46.75% | 50.44% | 47.73% |
| Operating Margin | -3213.56% | — | — | -53.78% | 2.13% | 23.67% | 34.16% | 32.91% |
| EBITDA Margin | -2622.62% | — | — | -48.97% | 3.70% | 25.09% | 35.26% | 33.14% |
| Net Margin | -11609.17% | — | — | -260.23% | 0.97% | 19.50% | 29.28% | 28.44% |
| Current Ratio | — | — | — | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — | — | — | — |
| Debt / Equity | — | — | — | — | — | — | 0.02 | 0.03 |
| ROE | -28.64% | -192.08% | -520.34% | -69.78% | 0.71% | 15.94% | 30.73% | 39.26% |
| ROA | -23.35% | -128.45% | -198.64% | -55.45% | 0.61% | 14.91% | 28.51% | 32.75% |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.21 | 0.63 | 0.76 | 0.97 | 1.15 |
| Book Value / Share | 34.32 | 109.21 | 2.44 | 1.91 | 74.65 | 66.76 | 2.65 | 1.94 |
Paranovus Entertainment Technology Ltd. is a diversified company focused on healthcare products, automotive-related activities, online retail, and internet information and advertising services. The company develops, manufactures, and sells nutraceutical and dietary supplement products in China and international markets, serving consumers seeking wellness-oriented products. In addition to its healthcare business, Paranovus Entertainment Technology Ltd. operates across multiple business segments that connect product development, digital commerce, and online marketing services. This mix of operations gives the company a broad presence across consumer-focused and technology-enabled markets. Headquartered in New York, Paranovus Entertainment Technology Ltd. positions itself as a multi-segment business with activities spanning health, commerce, and digital services.